These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15940417)

  • 1. Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases.
    Ferry T; Ponceau B; Simon M; Issartel B; Petiot P; Boibieux A; Biron F; Chidiac C; Peyramond D
    Infection; 2005 Jun; 33(3):151-4. PubMed ID: 15940417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linezolid-induced optic neuropathy.
    Saijo T; Hayashi K; Yamada H; Wakakura M
    Am J Ophthalmol; 2005 Jun; 139(6):1114-6. PubMed ID: 15953450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases.
    von der Lippe B; Sandven P; Brubakk O
    J Infect; 2006 Feb; 52(2):92-6. PubMed ID: 15907341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid-associated toxic optic neuropathy.
    Rucker JC; Hamilton SR; Bardenstein D; Isada CM; Lee MS
    Neurology; 2006 Feb; 66(4):595-8. PubMed ID: 16505322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linezolid-induced posterior reversible leukoencephalopathy syndrome.
    Nagel S; Köhrmann M; Huttner HB; Storch-Hagenlocher B; Schwab S
    Arch Neurol; 2007 May; 64(5):746-8. PubMed ID: 17502475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral neuropathy associated with prolonged use of linezolid.
    Bressler AM; Zimmer SM; Gilmore JL; Somani J
    Lancet Infect Dis; 2004 Aug; 4(8):528-31. PubMed ID: 15288827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6.
    Spellberg B; Yoo T; Bayer AS
    J Antimicrob Chemother; 2004 Oct; 54(4):832-5. PubMed ID: 15317746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
    Anger HA; Dworkin F; Sharma S; Munsiff SS; Nilsen DM; Ahuja SD
    J Antimicrob Chemother; 2010 Apr; 65(4):775-83. PubMed ID: 20150181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the safety of linezolid.
    Metaxas EI; Falagas ME
    Expert Opin Drug Saf; 2009 Jul; 8(4):485-91. PubMed ID: 19538105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin toxicity associated with concomitant use of linezolid.
    Bergeron L; Boulé M; Perreault S
    Ann Pharmacother; 2005 May; 39(5):956-61. PubMed ID: 15827071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid for the treatment of multidrug-resistant tuberculosis.
    Fortún J; Martín-Dávila P; Navas E; Pérez-Elías MJ; Cobo J; Tato M; De la Pedrosa EG; Gómez-Mampaso E; Moreno S
    J Antimicrob Chemother; 2005 Jul; 56(1):180-5. PubMed ID: 15911549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bell's palsy associated with linezolid therapy: case report and review of neuropathic adverse events.
    Thai XC; Bruno-Murtha LA
    Pharmacotherapy; 2006 Aug; 26(8):1183-9. PubMed ID: 16863496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid-associated toxic optic neuropathy: a report of 2 cases.
    Lee E; Burger S; Shah J; Melton C; Mullen M; Warren F; Press R
    Clin Infect Dis; 2003 Nov; 37(10):1389-91. PubMed ID: 14583875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid-associated peripheral neuropathy.
    Rho JP; Sia IG; Crum BA; Dekutoski MB; Trousdale RT
    Mayo Clin Proc; 2004 Jul; 79(7):927-30. PubMed ID: 15244392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of linezolid.
    French G
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii45-53. PubMed ID: 12730142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid-induced neuropathy.
    Legout L; Senneville E; Gomel JJ; Yazdanpanah Y; Mouton Y
    Clin Infect Dis; 2004 Mar; 38(5):767-8. PubMed ID: 14986270
    [No Abstract]   [Full Text] [Related]  

  • 17. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causal relationship between neuropathy and prolonged linezolid use.
    Frippiat F; Derue G
    Clin Infect Dis; 2004 Aug; 39(3):439. PubMed ID: 15307017
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sideroblastic anemia after prolonged linezolid therapy].
    Kakimoto T; Nakazato T; Miura R; Kurai H; Yamashita D; Sagara Y; Ishida A
    Rinsho Ketsueki; 2008 Nov; 49(11):1566-8. PubMed ID: 19047790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
    J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.